Русский
Vaccination against pneumococcal infection in patients with diabetes mellitus
DOI: https://dx.doi.org/10.18565/pharmateca.2024.8.33-39
Tarasova A.A., Kostinov M.P., Novopoltseva E.G.
1) Privolzhsky Research Medical University, Nizhny Novgorod, Russia; 2) I.I. Mechnikov Research Institute of Vaccines and Serums, Moscow, Russia; 3) I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia
The review highlights the relevance and necessity of vaccination against pneumococcal infection in the post-COVID period. A comparative analysis of vaccination schedules using conjugate and polysaccharide vaccines in patients with diabetes mellitus types 1 and 2 was carried out in accordance with foreign and domestic recommendations.
About the Autors
Corresponding author: Alla A. Tarasova, Dr. Sci. (Med.), Professor, Department of Faculty and Outpatient Pediatrics, Privolzhsky Research Medical University, Nizhny Novgorod, Russia; taras.al@mail.ru
Similar Articles
